VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AVTR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AVTRAvantor, Inc.
$10.20$7.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

AVTR logoAvantor, Inc.(AVTR)Earnings, Financials & Key Ratios

AVTR•NYSE
$10.20
Price updated Jul 7, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDiagnostics and life science tools
AboutAvantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.Show more
  • Revenue$6.55B-3.4%
  • EBITDA$164M-89.0%
  • Net Income-$530M-174.5%
  • EPS (Diluted)-0.78-175.0%
  • Gross Margin32.65%-2.8%
  • EBITDA Margin2.5%-88.6%
  • Operating Margin-3.76%-123.5%
  • Net Margin-8.09%-177.2%
  • ROE-9.2%-172.5%

AVTR Price & Volume

Avantor, Inc. (AVTR) stock price & volume — 10-year historical chart

Loading chart...

Persistent Revenue Stagnation Challenges Operational Margin Recovery

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Strained
Financial:Strained
Cash Flow:Mixed
Primary Risk:Operational margin volatility

Key Thesis Takeaways

  • Avantor faces a challenging fundamental outlook characterized by stagnant revenue growth, which hit 0.0% in 2026Q1, and structural margin compression as gross margins drifted down to 31.7%.
  • While the company has significantly reduced its debt profile to $37 million, the reliance on a $5.0 billion goodwill base and volatile working capital cycles suggests ongoing integration and demand risks.
  • Investors should remain cautious as the company navigates post-pandemic volume normalization and attempts to stabilize its core bioprocessing and laboratory supply segments.

Verdict Logic

the company's inability to generate consistent revenue growth, coupled with a 2026Q1 FCF margin of only 1.6%, suggests that operational headwinds currently outweigh the benefits of recent debt reduction.

AVTR Growth Metrics

Avantor, Inc. (AVTR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years0.49%
3 Years-4.46%
TTM-1.99%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-177.05%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-176.67%

Return on Capital

10 Years4.81%
5 Years6.43%
3 Years4.54%
Last Year-2.4%

AVTR Recent Earnings

Avantor, Inc. (AVTR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 29, 2026
Metric
Actual
Est
EPS
$0.17+8.3%
$0.16
Rev
$1.6B+2.5%
$1.5B
Q1 2026
Feb 11, 2026
Metric
Actual
Est
EPS
$0.22+4.8%
$0.21
Rev
$1.7B+1.6%
$1.6B
Q4 2025
Oct 29, 2025
Metric
Actual
Est
EPS
$0.22-2.1%
$0.22
Rev
$1.6B-1.3%
$1.6B
Q3 2025
Aug 1, 2025
Metric
Actual
Est
EPS
$0.24-4.0%
$0.25
Rev
$1.7B+2.3%
$1.6B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 29, 2026
$0.17vs $0.16+8.3%
$1.6Bvs $1.5B+2.5%
Q1 2026Feb 11, 2026
$0.22vs $0.21+4.8%
$1.7Bvs $1.6B+1.6%
Q4 2025Oct 29, 2025
$0.22vs $0.22-2.1%
$1.6Bvs $1.6B-1.3%
Q3 2025Aug 1, 2025
$0.24vs $0.25-4.0%
$1.7Bvs $1.6B+2.3%
Based on last 12 quarters of dataView full earnings history →

Latest AVTR News

Recent stock market news and headlines for Avantor, Inc. (AVTR)

PRNewsWire·6 days ago
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026

RADNOR, Pa., July 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m.

Peers Comparison

Key metrics vs top competitors for Avantor, Inc. (AVTR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
AVTR logoAVTRAvantor, Inc.Current
$10.20$6.96B-13.08-3.41%-8.09%-9.2%—
TMO logoTMOThermo Fisher Scientific Inc.
$516.62$191.99B29.123.91%15.18%13.23%—
DHR logoDHRDanaher Corporation
$194.19$137.44B38.532.9%14.89%7.06%—
MLAB logoMLABMesa Laboratories, Inc.
$96.16$531.28M79.473.38%2.69%3.71%—
SITE logoSITESiteOne Landscape Supply, Inc.
$109.99$4.87B32.643.62%3.24%9.09%—
WAT logoWATWaters Corporation
$374.93$24.44B34.846.99%11.91%8.04%—

Compare AVTR vs Peers

Avantor, Inc. (AVTR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TMO

Most directly comparable listed peer for AVTR.

Scale Benchmark

vs DHR

Larger-name benchmark to compare AVTR against a more recognizable public peer.

Peer Set

Compare Top 5

vs TMO, DHR, MLAB, SITE

AVTR SEC Filings & Documents

Avantor, Inc. (AVTR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 29, 2026·SEC

Material company update

Apr 23, 2026·SEC

Material company update

Apr 1, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 11, 2026·SEC

FY 2025

Feb 7, 2025·SEC

FY 2024

Feb 14, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 29, 2026·SEC

FY 2025

Oct 29, 2025·SEC

FY 2025

Aug 1, 2025·SEC

Get notified when AVTR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AVTR Frequently Asked Questions

Avantor, Inc. (AVTR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Avantor, Inc.'s revenue?

Avantor, Inc. (AVTR) reported $6.55B in revenue for fiscal year 2025. This represents a 848% increase from $691.3M in 2016.

How fast is Avantor, Inc. growing?

Avantor, Inc. (AVTR) saw revenue decline by 3.4% over the past year.

Is AVTR profitable?

Avantor, Inc. (AVTR) reported a net loss of $551.4M for fiscal year 2025.

Dividend & Returns
What is AVTR's return on equity?

Avantor, Inc. (AVTR) has a return on equity (ROE) of -9.2%. Negative ROE indicates the company is unprofitable.

What is Avantor, Inc.'s free cash flow?

Avantor, Inc. (AVTR) generated $438.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in AVTR back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →